Literature DB >> 20101092

The role of genetic diversity in cancer.

Lauren M F Merlo1, Carlo C Maley.   

Abstract

The role of genetic heterogeneity within neoplasms is increasingly recognized as important for understanding the dynamics of cancer progression, cancer stem cells, and therapeutic resistance, and there is interest in intratumoral heterogeneity measurements as potential biomarkers for risk stratification. In this issue of the JCI, Park et al. characterize this genetic diversity in carcinoma in situ and in invasive regions from 3 types of human breast cancers and lay the groundwork for translation of these measures to the clinic.

Entities:  

Mesh：

Year:  2010        PMID： 20101092      PMCID： PMC2810093          DOI： 10.1172/JCI42088

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


  17 in total

1.  CYTOGENETIC EVIDENCE OF CLONAL PROLIFERATION IN PRIMARY RETICULAR NEOPLASMS.

Authors:  C E FORD; C M CLARKE
Journal:  Proc Can Cancer Conf       Date:  1963

Review 2.  Biomarkers in cancer staging, prognosis and treatment selection.

Authors:  Joseph A Ludwig; John N Weinstein
Journal:  Nat Rev Cancer       Date:  2005-11       Impact factor: 60.716

3.  Models for clonal evolutions: a study of chronic myelogenous leukemia.

Authors:  J de Grouchy; C de Nava; J M Cantu; G Bilski-Pasquier; J Bousser
Journal:  Am J Hum Genet       Date:  1966-09       Impact factor: 11.025

4.  Genetic clonal diversity predicts progression to esophageal adenocarcinoma.

Authors:  Carlo C Maley; Patricia C Galipeau; Jennifer C Finley; V Jon Wongsurawat; Xiaohong Li; Carissa A Sanchez; Thomas G Paulson; Patricia L Blount; Rosa-Ana Risques; Peter S Rabinovitch; Brian J Reid
Journal:  Nat Genet       Date:  2006-03-26       Impact factor: 38.330

5.  Colorectal adenoma and cancer divergence. Evidence of multilineage progression.

Authors:  J L Tsao; S Tavaré; R Salovaara; J R Jass; L A Aaltonen; D Shibata
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

Review 6.  Microenvironmental regulation of cancer development.

Authors:  Min Hu; Kornelia Polyak
Journal:  Curr Opin Genet Dev       Date:  2008-02-20       Impact factor: 5.578

Review 7.  Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits.

Authors:  Kornelia Polyak; Robert A Weinberg
Journal:  Nat Rev Cancer       Date:  2009-03-05       Impact factor: 60.716

8.  NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma.

Authors:  Patricia C Galipeau; Xiaohong Li; Patricia L Blount; Carlo C Maley; Carissa A Sanchez; Robert D Odze; Kamran Ayub; Peter S Rabinovitch; Thomas L Vaughan; Brian J Reid
Journal:  PLoS Med       Date:  2007-02       Impact factor: 11.069

9.  Sequential ABL kinase inhibitor therapy selects for compound drug-resistant BCR-ABL mutations with altered oncogenic potency.

Authors:  Neil P Shah; Brian J Skaggs; Susan Branford; Timothy P Hughes; John M Nicoll; Ronald L Paquette; Charles L Sawyers
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

10.  Efficient tumour formation by single human melanoma cells.

Authors:  Elsa Quintana; Mark Shackleton; Michael S Sabel; Douglas R Fullen; Timothy M Johnson; Sean J Morrison
Journal:  Nature       Date:  2008-12-04       Impact factor: 49.962
View more
  26 in total

Review 1.  Research Needs for Understanding the Biology of Overdiagnosis in Cancer Screening.

Authors:  Sudhir Srivastava; Brian J Reid; Sharmistha Ghosh; Barnett S Kramer
Journal:  J Cell Physiol       Date:  2016-04-29       Impact factor: 6.384

2.  Prediagnostic Obesity and Physical Inactivity Are Associated with Shorter Telomere Length in Prostate Stromal Cells.

Authors:  Corinne E Joshu; Sarah B Peskoe; Christopher M Heaphy; Stacey A Kenfield; Erin L Van Blarigan; Lorelei A Mucci; Edward L Giovannucci; Meir J Stampfer; GhilSuk Yoon; Thomas K Lee; Jessica L Hicks; Angelo M De Marzo; Alan K Meeker; Elizabeth A Platz
Journal:  Cancer Prev Res (Phila)       Date:  2015-05-19

Review 3.  Evolutionary scalpels for dissecting tumor ecosystems.

Authors:  Daniel I S Rosenbloom; Pablo G Camara; Tim Chu; Raul Rabadan
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2016-12-05       Impact factor: 10.680

Review 4.  Natural Selection in Cancer Biology: From Molecular Snowflakes to Trait Hallmarks.

Authors:  Angelo Fortunato; Amy Boddy; Diego Mallo; Athena Aktipis; Carlo C Maley; John W Pepper
Journal:  Cold Spring Harb Perspect Med       Date:  2017-02-01       Impact factor: 6.915

Review 5.  Cancer in light of experimental evolution.

Authors:  Kathleen Sprouffske; Lauren M F Merlo; Philip J Gerrish; Carlo C Maley; Paul D Sniegowski
Journal:  Curr Biol       Date:  2012-09-11       Impact factor: 10.834

6.  Aberrant intestinal stem cell lineage dynamics in Peutz-Jeghers syndrome and familial adenomatous polyposis consistent with protracted clonal evolution in the crypt.

Authors:  Danielle Langeveld; Marnix Jansen; D V de Boer; Mariska van Sprundel; Lodewijk A A Brosens; Folkert H Morsink; Francis M Giardiello; G Johan A Offerhaus; Wendy W J de Leng
Journal:  Gut       Date:  2011-09-22       Impact factor: 23.059

7.  Clinical significance of the stem cell gene Oct-4 in cervical cancer.

Authors:  Yanyan Yang; Yimin Wang; Chunxia Yin; Xiuying Li
Journal:  Tumour Biol       Date:  2014-02-16

8.  Current or recent smoking is associated with more variable telomere length in prostate stromal cells and prostate cancer cells.

Authors:  Corinne E Joshu; Sarah B Peskoe; Christopher M Heaphy; Stacey A Kenfield; Lorelei A Mucci; Edward L Giovannucci; Meir J Stampfer; Ghilsuk Yoon; Thomas K Lee; Jessica L Hicks; Angelo M De Marzo; Alan K Meeker; Elizabeth A Platz
Journal:  Prostate       Date:  2017-11-22       Impact factor: 4.104

9.  Clinicopathological significance of cancer stem-like cell markers in high-grade neuroendocrine carcinoma of the lung.

Authors:  Masahiro Morise; Tomoyuki Hishida; Akiko Takahashi; Junji Yoshida; Yuichiro Ohe; Kanji Nagai; Genichiro Ishii
Journal:  J Cancer Res Clin Oncol       Date:  2015-05-12       Impact factor: 4.553

10.  Prostate cancer cell telomere length variability and stromal cell telomere length as prognostic markers for metastasis and death.

Authors:  Christopher M Heaphy; Ghil Suk Yoon; Sarah B Peskoe; Corinne E Joshu; Thomas K Lee; Edward Giovannucci; Lorelei A Mucci; Stacey A Kenfield; Meir J Stampfer; Jessica L Hicks; Angelo M De Marzo; Elizabeth A Platz; Alan K Meeker
Journal:  Cancer Discov       Date:  2013-06-18       Impact factor: 39.397
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.